All India Institute Of Medical Sciences 1
1. Global, regional, and national incidence and mortality burden of non-COVID-19 lower respiratory infections and aetiologies, 1990–2021: a systematic analysis from the Global Burden of Disease Study 2021
2. Evaluation of a quality improvement intervention to reduce anastomotic leak following right colectomy (EAGLE): pragmatic, batched stepped-wedge, cluster-randomized trial in 64 countries
3. Global, regional, and national burden of HIV/AIDS, 1990–2021, and forecasts to 2050, for 204 countries and territories: the Global Burden of Disease Study 2021
4. Recovery of cardiovascular testing in Asia during the COVID-19 pandemic: findings from the INCAPS COVID 2 study
5. Recovery of cardiovascular testing in Asia during the COVID-19 pandemic: findings from the INCAPS COVID 2 study
6. Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study
7. Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study
8. The global, regional, and national burden attributable to low bone mineral density, 1990–2020: an analysis of a modifiable risk factor from the Global Burden of Disease Study 2021
9. Heterogeneous contributions of change in population distribution of body mass index to change in obesity and underweight
10. Multi-ancestry genome-wide association meta-analysis of Parkinson’s disease
11. Impact of COVID-19 Pandemic on Cardiovascular Testing in Asia: The IAEA INCAPS-COVID Study
12. Author Correction: Elucidating causative gene variants in hereditary Parkinson’s disease in the Global Parkinson’s Genetics Program (GP2) (npj Parkinsons Disease, (2023), 9, 1, (100), 10.1038/s41531-023-00526-9)
13. The LRRK2 p.L1795F variant causes Parkinson’s disease in the European population
14. A global action agenda for turning the tide on fatty liver disease
15. Global, regional, and national age-specific progress towards the 2020 milestones of the WHO End TB Strategy: a systematic analysis for the Global Burden of Disease Study 2021
16. Association of LRRK2 p.A419V with Parkinson’s Disease in East Asians and analysis of age at onset
17. Development of the global inflammatory bowel disease visualization of epidemiology studies in the 21st century (GIVES-21)
18. Diminishing benefits of urban living for children and adolescents’ growth and development
19. Burden of disease scenarios by state in the USA, 2022–50: a forecasting analysis for the Global Burden of Disease Study 2021
20. The burden of diseases, injuries, and risk factors by state in the USA, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
21. Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050
22. SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study
23. SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study
24. IGCS 2024 Dublin: Highlights of research presented at the annual meeting
25. Global, regional, and national burden of chronic respiratory diseases and impact of the COVID-19 pandemic, 1990–2023: a Global Burden of Disease study
26. Global estimates on the number of people blind or visually impaired by cataract: a meta-analysis from 2000 to 2020
27. Global, Regional, and National Burden of Nontraumatic Subarachnoid Hemorrhage The Global Burden of Disease Study 2021
28. Insights into ancestral diversity in Parkinson’s disease risk: a comparative assessment of polygenic risk scores
29. Global, regional, and national burden of upper respiratory infections and otitis media, 1990-2021: a systematic analysis from the Global Burden of Disease Study 2021
30. Global, Regional, and National Burden of Cardiovascular Diseases and Risk Factors in 204 Countries and Territories, 1990-2023
31. Changing life expectancy in European countries 1990–2021: a subanalysis of causes and risk factors from the Global Burden of Disease Study 2021
32. Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
33. TMEM175, SCARB2 and CTSB associations with Parkinson’s disease risk across populations
34. Defining the causes of sporadic Parkinson’s disease in the global Parkinson’s genetics program (GP2)
35. Global, regional, and national mortality among young people aged 10–24 years, 1950–2019: a systematic analysis for the Global Burden of Disease Study 2019
36. Global, regional, and national burden of suicide, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021
37. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants
1